hematoencefalic

Hematoencefalic is an adjective used in some languages to denote relation to the interface between blood and brain, especially with reference to the barrier that regulates molecular exchange between the circulatory system and the central nervous system. In English, the preferred term is the blood-brain barrier (BBB), and hematoencefalic is encountered mainly in historical or translational contexts to describe barrier-related phenomena or transport across this interface.

The blood-brain barrier is a highly selective, semipermeable border formed primarily by brain microvascular endothelial cells joined by tight junctions, along with a supporting basement membrane, pericytes, and astrocyte end-feet. It restricts the passage of pathogens and large or hydrophilic molecules while allowing essential nutrients and gases to reach neural tissue. Transport occurs via paracellular restriction; transcellular diffusion for lipid-soluble substances; carrier-mediated transport for glucose and amino acids; and active efflux pumps that remove certain drugs from the brain.

Disruption of the hematoencephalic barrier can occur in infection, stroke, inflammatory brain diseases, trauma, and metabolic disorders, potentially leading to edema, neuronal injury, or altered drug delivery. Conversely, strategies to bypass or transiently modulate the barrier are studied to improve delivery of therapeutics to the CNS.

Usage and terminology: hematoencefalic terms are used primarily in non-English medical literature or historical texts; in English, authors typically use "blood-brain barrier" for clarity. The concept is central to neurology, pharmacology, and neuroimmunology.